CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) Fundamental Analysis & Valuation

NASDAQ:CCLDO • US14167R3084

25.54 USD
-0.11 (-0.43%)
Last: Mar 6, 2026, 05:04 PM

This CCLDO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Taking everything into account, CCLDO scores 5 out of 10 in our fundamental rating. CCLDO was compared to 35 industry peers in the Health Care Technology industry. CCLDO has an average financial health and profitability rating. CCLDO is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. CCLDO Profitability Analysis

1.1 Basic Checks

  • CCLDO had positive earnings in the past year.
  • CCLDO had a positive operating cash flow in the past year.
  • CCLDO had negative earnings in each of the past 5 years.
  • CCLDO had a positive operating cash flow in 4 of the past 5 years.
CCLDO Yearly Net Income VS EBIT VS OCF VS FCFCCLDO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

1.2 Ratios

  • CCLDO has a Return On Assets of 2.63%. This is amongst the best in the industry. CCLDO outperforms 88.57% of its industry peers.
  • With an excellent Return On Equity value of 4.12%, CCLDO belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 13.98%, CCLDO belongs to the top of the industry, outperforming 94.29% of the companies in the same industry.
Industry RankSector Rank
ROA 2.63%
ROE 4.12%
ROIC 13.98%
ROA(3y)-32.11%
ROA(5y)-24.15%
ROE(3y)-57.71%
ROE(5y)-41.4%
ROIC(3y)N/A
ROIC(5y)N/A
CCLDO Yearly ROA, ROE, ROICCCLDO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

  • CCLDO has a better Profit Margin (2.08%) than 82.86% of its industry peers.
  • CCLDO has a Operating Margin of 10.43%. This is amongst the best in the industry. CCLDO outperforms 85.71% of its industry peers.
  • In the last couple of years the Operating Margin of CCLDO has grown nicely.
  • CCLDO has a Gross Margin of 46.49%. This is in the lower half of the industry: CCLDO underperforms 74.29% of its industry peers.
  • In the last couple of years the Gross Margin of CCLDO has grown nicely.
Industry RankSector Rank
OM 10.43%
PM (TTM) 2.08%
GM 46.49%
OM growth 3Y59.79%
OM growth 5Y95.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.11%
GM growth 5Y4.51%
CCLDO Yearly Profit, Operating, Gross MarginsCCLDO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

5

2. CCLDO Health Analysis

2.1 Basic Checks

  • CCLDO has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • CCLDO has more shares outstanding than it did 1 year ago.
  • CCLDO has more shares outstanding than it did 5 years ago.
  • CCLDO has a better debt/assets ratio than last year.
CCLDO Yearly Shares OutstandingCCLDO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CCLDO Yearly Total Debt VS Total AssetsCCLDO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

  • An Altman-Z score of 20.70 indicates that CCLDO is not in any danger for bankruptcy at the moment.
  • CCLDO has a better Altman-Z score (20.70) than 100.00% of its industry peers.
  • CCLDO has a debt to FCF ratio of 0.38. This is a very positive value and a sign of high solvency as it would only need 0.38 years to pay back of all of its debts.
  • CCLDO has a better Debt to FCF ratio (0.38) than 71.43% of its industry peers.
  • CCLDO has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
  • CCLDO has a Debt to Equity ratio of 0.12. This is comparable to the rest of the industry: CCLDO outperforms 45.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 0.38
Altman-Z 20.7
ROIC/WACC1.48
WACC9.46%
CCLDO Yearly LT Debt VS Equity VS FCFCCLDO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • A Current Ratio of 1.26 indicates that CCLDO should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.26, CCLDO is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
  • CCLDO has a Quick Ratio of 1.15. This is a normal value and indicates that CCLDO is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of CCLDO (1.15) is worse than 74.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.15
CCLDO Yearly Current Assets VS Current LiabilitesCCLDO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

5

3. CCLDO Growth Analysis

3.1 Past

  • CCLDO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 107.27%, which is quite impressive.
  • CCLDO shows a small growth in Revenue. In the last year, the Revenue has grown by 2.97%.
  • Measured over the past years, CCLDO shows a quite strong growth in Revenue. The Revenue has been growing by 11.47% on average per year.
EPS 1Y (TTM)107.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)2.97%
Revenue growth 3Y-7.4%
Revenue growth 5Y11.47%
Sales Q2Q%8.83%

3.2 Future

  • The Earnings Per Share is expected to grow by 43.73% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 8.34% on average over the next years. This is quite good.
EPS Next Y143.35%
EPS Next 2Y60.03%
EPS Next 3Y43.73%
EPS Next 5YN/A
Revenue Next Year6.69%
Revenue Next 2Y9.34%
Revenue Next 3Y8.34%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CCLDO Yearly Revenue VS EstimatesCCLDO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2030 100M 200M 300M
CCLDO Yearly EPS VS EstimatesCCLDO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

3

4. CCLDO Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 638.50, which means the current valuation is very expensive for CCLDO.
  • 62.86% of the companies in the same industry are more expensive than CCLDO, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 26.29. CCLDO is valued rather expensively when compared to this.
  • With a Price/Forward Earnings ratio of 227.63, CCLDO can be considered very expensive at the moment.
  • CCLDO's Price/Forward Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.60, CCLDO is valued quite expensively.
Industry RankSector Rank
PE 638.5
Fwd PE 227.63
CCLDO Price Earnings VS Forward Price EarningsCCLDO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 200 400 600

4.2 Price Multiples

  • CCLDO's Enterprise Value to EBITDA is on the same level as the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CCLDO is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 59.82
EV/EBITDA 41.23
CCLDO Per share dataCCLDO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of CCLDO may justify a higher PE ratio.
  • A more expensive valuation may be justified as CCLDO's earnings are expected to grow with 43.73% in the coming years.
PEG (NY)4.45
PEG (5Y)N/A
EPS Next 2Y60.03%
EPS Next 3Y43.73%

5

5. CCLDO Dividend Analysis

5.1 Amount

  • CCLDO has a Yearly Dividend Yield of 9.99%, which is a nice return.
  • CCLDO's Dividend Yield is rather good when compared to the industry average which is at 0.60. CCLDO pays more dividend than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, CCLDO pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.99%

5.2 History

  • CCLDO has been paying a dividend for over 5 years, so it has already some track record.
  • The dividend of CCLDO decreased recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
CCLDO Yearly Dividends per shareCCLDO Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

DPN/A
EPS Next 2Y60.03%
EPS Next 3Y43.73%
CCLDO Yearly Income VS Free CF VS DividendCCLDO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

CCLDO Fundamentals: All Metrics, Ratios and Statistics

CARECLOUD INC - CCLD 8 3/4 PERP

NASDAQ:CCLDO (3/6/2026, 5:04:18 PM)

25.54

-0.11 (-0.43%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-06
Earnings (Next)03-12
Inst Owners25.28%
Inst Owner ChangeN/A
Ins Owners14.61%
Ins Owner ChangeN/A
Market Cap1.08B
Revenue(TTM)114.31M
Net Income(TTM)2.38M
Analysts80
Price Target61.72 (141.66%)
Short Float %0%
Short Ratio0.21
Dividend
Industry RankSector Rank
Dividend Yield 9.99%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-Date03-31
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)63.4%
Min EPS beat(2)30.72%
Max EPS beat(2)96.08%
EPS beat(4)4
Avg EPS beat(4)62.09%
Min EPS beat(4)21.57%
Max EPS beat(4)100%
EPS beat(8)6
Avg EPS beat(8)6.7%
EPS beat(12)8
Avg EPS beat(12)0.7%
EPS beat(16)12
Avg EPS beat(16)12.54%
Revenue beat(2)1
Avg Revenue beat(2)2.58%
Min Revenue beat(2)-1.27%
Max Revenue beat(2)6.44%
Revenue beat(4)2
Avg Revenue beat(4)2.42%
Min Revenue beat(4)-1.27%
Max Revenue beat(4)6.44%
Revenue beat(8)2
Avg Revenue beat(8)-0.78%
Revenue beat(12)2
Avg Revenue beat(12)-2.4%
Revenue beat(16)3
Avg Revenue beat(16)-2.05%
PT rev (1m)11.24%
PT rev (3m)33.83%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 638.5
Fwd PE 227.63
P/S 9.47
P/FCF 59.82
P/OCF 42.42
P/B 18.73
P/tB 176.48
EV/EBITDA 41.23
EPS(TTM)0.04
EY0.16%
EPS(NY)0.11
Fwd EY0.44%
FCF(TTM)0.43
FCFY1.67%
OCF(TTM)0.6
OCFY2.36%
SpS2.7
BVpS1.36
TBVpS0.14
PEG (NY)4.45
PEG (5Y)N/A
Graham Number1.11
Profitability
Industry RankSector Rank
ROA 2.63%
ROE 4.12%
ROCE 17.7%
ROIC 13.98%
ROICexc 14.93%
ROICexgc 82.32%
OM 10.43%
PM (TTM) 2.08%
GM 46.49%
FCFM 15.84%
ROA(3y)-32.11%
ROA(5y)-24.15%
ROE(3y)-57.71%
ROE(5y)-41.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y52.71%
ROICexgc growth 5Y104.32%
ROICexc growth 3Y91.65%
ROICexc growth 5Y92.03%
OM growth 3Y59.79%
OM growth 5Y95.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.11%
GM growth 5Y4.51%
F-Score6
Asset Turnover1.26
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 0.38
Debt/EBITDA 0.26
Cap/Depr 51.55%
Cap/Sales 6.5%
Interest Coverage 118.08
Cash Conversion 96.95%
Profit Quality 760.91%
Current Ratio 1.26
Quick Ratio 1.15
Altman-Z 20.7
F-Score6
WACC9.46%
ROIC/WACC1.48
Cap/Depr(3y)74.91%
Cap/Depr(5y)76.9%
Cap/Sales(3y)8.36%
Cap/Sales(5y)8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y143.35%
EPS Next 2Y60.03%
EPS Next 3Y43.73%
EPS Next 5YN/A
Revenue 1Y (TTM)2.97%
Revenue growth 3Y-7.4%
Revenue growth 5Y11.47%
Sales Q2Q%8.83%
Revenue Next Year6.69%
Revenue Next 2Y9.34%
Revenue Next 3Y8.34%
Revenue Next 5YN/A
EBIT growth 1Y128.34%
EBIT growth 3Y47.96%
EBIT growth 5Y117.42%
EBIT Next Year218.16%
EBIT Next 3Y57.55%
EBIT Next 5YN/A
FCF growth 1Y212.1%
FCF growth 3Y68.43%
FCF growth 5Y21.21%
OCF growth 1Y43.66%
OCF growth 3Y15.69%
OCF growth 5Y22.06%

CARECLOUD INC - CCLD 8 3/4 PERP / CCLDO FAQ

What is the ChartMill fundamental rating of CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CCLDO.


What is the valuation status of CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) stock?

ChartMill assigns a valuation rating of 3 / 10 to CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO). This can be considered as Overvalued.


How profitable is CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) stock?

CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) has a profitability rating of 6 / 10.


What is the expected EPS growth for CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) stock?

The Earnings per Share (EPS) of CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) is expected to grow by 143.35% in the next year.